Sean Lee
Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
About Sean Lee
Sean Lee is recorded as Analyst at H.C. Wainwright. Sean Lee has spoken on 10 earnings calls and 1 other investor event across 6 companies, most recently for Myomo, Inc. on September 16, 2026. Those appearances were for Senseonics Holdings, Inc. (SENS), Cytosorbents Corp (CTSO), Alphatec Holdings, Inc. (ATEC), Corvus Pharmaceuticals, Inc. (CRVS), Myomo, Inc. (MYO) and 1 other company. The companies whose calls Sean Lee spoke on are classified in the Healthcare sector.
Sean Lee on recent calls
“Good morning, everyone, and thank you for joining us at the 28th Annual HC Wingright Global Investment Conference. My name is Sean Lee. I'm a Senior Biotech Analyst at the bank.”
“For Germany, do you expect to come, sorry, do you expect to, how long do you expect these new reps to become a critical to the revenues? and do you think they'll be sufficient to return the country to growth?”
“And on a longer-term perspective, do you value breath more and using more surgeons or depth and more procedures per surgeon? Thanks.”
“Wainwright Your line is open Good afternoon, guys, and thanks for taking my questions. In the preparing remarks, you mentioned that DTC is becoming an increasing larger piece that the new patient has.”
Affiliation history
-
H.C. Wainwright
Analyst
Transcript header (unverified)
Current
Company network
Cytosorbents Corp
CTSO
Medical Devices · Healthcare
2 appearances
Latest appearance 2026-08-06
View calls and events
Myomo, Inc.
MYO
Medical Devices · Healthcare
1 appearance
Latest appearance 2026-09-16
View calls and events
Verastem, Inc.
VSTM
Biotechnology · Healthcare
1 appearance
Latest appearance 2025-11-04
View calls and events